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Metal-on-metal (MoM) hip replacements, often manufactured from a cobalt-chrome alloy, are associated
with adverse reactions including soft tissue necrosis and osteolysis. Histopathological analysis of MoM
peri-implant tissues reveals an inﬂammatory cell inﬁltrate that includes macrophages, monocytes and
neutrophils.
Toll-like receptor 4 (TLR4) is an innate immune receptor activated by bacterial lipopolysaccharide.
Recent studies have demonstrated that cobalt ions from metal-on-metal joints also activate human TLR4,
increasing cellular secretion of inﬂammatory chemokines including interleukin-8 (IL-8, CXCL8) and CCL2.
Chemokines recruit immune cells to the site of inﬂammation, and their overall effect depends on the
chemokine proﬁle produced.
This study investigated the effect of cobalt on the secretion of inﬂammatory cytokines CCL20 and IL-6.
The chemotactic potential of conditioned media from a cobalt-stimulated human monocyte cell line on
primary monocytes and neutrophils was investigated using an in vitro transwell migration assay. The role
of TLR4 in observed effects was studied using a small molecule TLR4-speciﬁc antagonist.
Cobalt ions signiﬁcantly increased release of CCL2 and IL-6 by MonoMac 6 cells (Po0.001). Condi-
tioned media from cobalt-stimulated cells signiﬁcantly increased monocyte and neutrophil chemotaxis
in vitro (Po0.001). These effects were abrogated by the TLR4 antagonist (Po0.001) suggesting that they
occur through cobalt activation of TLR4.
This study demonstrates the role of TLR4 in cobalt-mediated immune cell chemotaxis and provides a
potential mechanism by which cobalt ions may contribute to the immune cell inﬁltrate surrounding
failed metal hip replacements. It also highlights the TLR4 signalling pathway as a potential therapeutic
target in preventing cobalt-mediated inﬂammation.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Metal-on-metal (MoM) hip replacements are associated with
elevated failure rates due to the development of adverse reactions
to metal debris (ARMD) which include osteolysis, soft tissue ne-
crosis, pain, and benign but inﬂammatory pseudotumours [1,2].
Tissues surrounding failed MoM joints are inﬁltrated by immune
cells including mononuclear phagocytes [3], lymphocytes [4] and
neutrophils [3]. Once inside tissues these cells can carry out theiran open access article under the C
se reactions to metal debris;
wrence),
@nuth.nhs.uk (J.P. Holland),
tlook.com (A.E. Mawdesley),
ncl.ac.uk (A.J. Tyson-Capper).effector functions that lead to an inﬂammatory response but the
mechanisms by which they are recruited are currently unclear.
Cobalt ions released during wear of MoM implants activate
human Toll-like receptor 4 (TLR4) [5–8], an innate immune re-
ceptor expressed on the surface of numerous cell types, including
macrophages, dendritic cells and endothelial cells. TLR4 is also
activated by lipopolysaccharide (LPS) to protect against Gram ne-
gative bacterial infection and resulting sepsis. The recent discovery
of cobalt as a TLR4 agonist has led to several studies highlighting
the subsequent cellular events, speciﬁcally the release of pro-in-
ﬂammatory cytokines and chemokines including interleukin-6 (IL-
6), interleukin-8 (IL-8) [9], chemokine (C-X-C motif) ligand 10
(CXCL10) [9] and chemokine (C-C motif) ligand 2 (CCL2) [10].
Chemokines are small (10–12 kDa) secreted molecules that co-
ordinate the immune response. In vivo they form a chemokine
gradient to guide target cells towards the site of inﬂammation, and
exert their effects through G protein-coupled receptors on theseC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Effect of cobalt-mediated TLR4 activation on CCL20 and IL-6 secretion. MonoMac 6 cells were pre-treated with 1 μg/ml CLI-095 for 6 h prior to 24 h stimulation with
0.75 mM CoCl2 or 100 ng/ml LPS. A. CCL20 and B. IL-6 secretion was assessed by ELISA. Data is representative of three independent experiments and statistical signiﬁcance
was calculated by one-way ANOVA with Tukey's test for multiple comparisons comparing al samples to each other.
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target cell; for example IL-8 is chemotactic for neutrophils [12],
while CCL2 acts on monocytes to direct them to the site of in-
ﬂammation [13].
The individual effect of most chemokines is well-described.
However the immunological outcome is dependent on the overall
chemokine proﬁle produced in response to a pathogen and the
chemotactic effect of cobalt is currently unknown.
This study set out to determine the effect of cobalt ions on the
migration of immune cells and the role of TLR4 in any observed
responses to establish whether cobalt may contribute to the in-
ﬂammatory inﬁltrate surrounding failed MoM hip replacements.2. Materials and methods
2.1. Cell culture
MonoMac 6 cells are a human cell line derived from acute
monocytic leukaemia. They are known to be LPS-responsive
through their expression of TLR4 [14]. Cells were cultured in RPMI-
1640 medium (Sigma Aldrich, Gillingham, UK) supplemented with
10% FBS, 50 U/ml penicillin, 50 μg/ml streptomycin and 2 mM L-
glutamine (all Sigma Aldrich).
2.2. Metal ion stimulation
Cobalt chloride hexahydrate (CoCl2) (Sigma Aldrich) was di-
luted in complete cell culture media prior to cell stimulation.
MonoMac 6 cells were treated with 0.75 mM CoCl2, a clinically-
relevant concentration optimised in a previous study [9]. 100 ng/
ml TLR4-speciﬁc LPS (from E.coli serotype J5, Alexis Biochemicals,
San Diego, USA) as a positive control for 24 h after which super-
natant (termed 'conditioned media') was collected.
2.3. TLR4 antagonist
CLI-095 (Invivogen, Toulouse, France) is a small molecule an-
tagonist that binds to the intracellular domain of TLR4 to prevent
recruitment of adaptor proteins and subsequent downstream
signalling. MonoMac 6 cells were pre-treated with 1 μg/ml CLI-
095 for 6 h prior to stimulation with 0.75 mM CoCl2 or 100 ng/ml
LPS. Enzyme-linked immunosorbent assay (ELISA).
Cytokine secretion was quantiﬁed by enzyme-linked im-
munosorbent assay (ELISA). An IL-6 ELISA kit (Peprotech, London,
UK) was used according to the manufacturer’s protocol with the
same minor modiﬁcation as described previously for an IL-8 ELISA
[9]. CCL20 was quantiﬁed using a DuoSet ELISA kit (R&D Systems,Abingdon, UK) according to the manufacturer’s protocol.
2.4. Monocyte and neutrophil isolation
Monocytes and neutrophils were isolated from whole blood of
healthy volunteers. Monocytes were isolated using Lympholyte
(Cedarlane, Burlington, USA) according to the manufacturer's
protocol and neutrophils were isolated by dextran sedimentation
(Dextran T500, Pharmacosmos, Holbaek, Denmark) and cen-
trifugation on Percoll (GE Healthcare, Buckinghamshire, UK) den-
sity gradients as previously described [15].
2.5. Transwell migration assay
Following isolation cells were resuspended in RPMI-1640
medium (Sigma Aldrich) supplemented with 10% FBS and 2 mM L-
glutamine. Conditioned media from MonoMac 6 cells was added
to the lower chamber of a 24-well companion plate (BD Falcon,
New Jersey, USA). LPS conditioned media was used as a positive
control and complete RPMI-1640 media provided a negative con-
trol. Three technical replicates were included for each condition. A
Falcon cell culture insert with 3 mm pores (VWR Systems, Penn-
sylvania, USA) was placed in each well. 500,000 monocytes or
neutrophils were added to the upper chamber of each ﬁlter and
incubated at 37 °C for 2 h to allow for chemotaxis. Migrated
monocytes and neutrophils pass through the pores in the cell
culture insert and adhere to the underside of the ﬁlter.
Filters were ﬁxed in methanol before staining migrated cells
with haematoxylin. Following ﬁxation, ﬁlters were air-dried for
3 h, excised, and mounted using DPX mountant (Sigma Aldrich).
Five different visual ﬁelds were selected per ﬁlter and attached
cells were counted at 40 magniﬁcation.
2.6. Statistical analysis
Data was analysed using GraphPad Prism 6 software (Graph-
Pad, California, USA). A Student’s t test was used for statistical
analysis unless otherwise stated, with po0.05 considered sig-
niﬁcant. All error bars show the standard error of the mean (SEM).3. Results
We have previously described TLR4-dependent IL-8 and
CXCL10 secretion by cobalt-stimulated MonoMac 6 cells [9], as
well as increased CCL20 and IL1A expression [16]. For the present
study we have further investigated the effects of cobalt-mediated
TLR4 activation on cytokine secretion by studying CCL20 and IL-6.
Fig. 2. Effect of cobalt ions on monocyte chemotaxis. A. Filters stained with haematoxylin showing migrated monocytes at 40 magniﬁcation. B. Migrated monocytes were
counted at 40 magniﬁcation. There was a signiﬁcant increase in monocyte migration in response to 0.75 mM CoCl2 and 100 ng/ml LPS (24 h treatment) conditioned media
compared to untreated controls. 1 mg/ml CLI-095 abrogated the CoCl2-induced effect (Po0.001). The effect of LPS was also inhibited demonstrating that the antagonist is
speciﬁc for TLR4. CLI-095 had no effect on migration in untreated controls (P¼0.78). Data is representative of three independent experiments each using a different
monocyte donor. ***¼Po0.001, Student's t-test.
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prior to 24 h stimulation with 0.75 mM CoCl2 or 100 ng/ml TLR4-
speciﬁc LPS as a positive control. In response to CoCl2 there was a
signiﬁcant increase in CCL20 secretion to approximately 300 pg/ml
(Po0.001) (Fig. 1A). Pre-treatment with the TLR4 antagonist de-
creased CoCl2-mediated CCL20 release to o10 pg/ml (Po0.001).
This was comparable to the CCL20 response to LPS, which was also
signiﬁcantly increased by the ligand and inhibited by CLI-095
(both Po0.001) (Fig. 1A). LPS increased IL-6 secretion by Mono-
Mac 6 cells to approximately 2000 pg/ml (Po0.001), and this was
signiﬁcantly inhibited by CLI-095 (Po0.001) (Fig. 1B). In responseto CoCl2 stimulation there was also a signiﬁcant upregulation in IL-
6 release but only to 350 pg/ml (P¼0.045) (Fig. 1B). Although CLI-
095 reduced CoCl2-mediated IL-6 release to approximately 50 pg/
ml, this did not reach statistical signiﬁcance (P¼0.080) (Fig. 1B).
However from the data obtained it is clear that cobalt ions can
increase secretion of pro-inﬂammatory cytokines and chemokines
through activation of TLR4.
The effect of cobalt ions on monocyte and neutrophil chemo-
taxis was investigated due to the presence of these innate immune
cells around failed MoM implants, increased chemokine secretion
in response to cobalt, and the role of TLR4 in innate immunity
Fig. 3. Effect of cobalt ions on neutrophil chemotaxis. A. Filters stained with haematoxylin showing migrated neutrophils at 40 magniﬁcation. B. Migrated neutrophils
were counted at 40 magniﬁcation. Neutrophil migration was signiﬁcantly increased in response to 0.75 mM CoCl2 and 100 ng/ml LPS (24 h) conditioned media from
MonoMac 6 cells compared to untreated controls. 1 mg/ml CLI-095 signiﬁcantly abrogated the observed CoCl2-mediated chemotaxis (Po0.001). LPS-induced neutrophil
chemotaxis was also inhibited by CLI-095 (Po0.001). Data is representative of three independent experiments each using a different neutrophil donor. ***¼Po0.001,
Student's t-test.
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to inhibit cobalt-induced chemokine secretion by MonoMac 6 cells
[9] and was used to investigate the role of TLR4 in cobalt-mediated
monocyte and neutrophil chemotaxis.
MonoMac 6 cells were left untreated or pre-treated with 1 μg/
ml CLI-095 for 6 h, followed by 24 h treatment with 100 ng/ml LPS
or 0.75 mM CoCl2. A transwell migration assay was then con-
ducted using the conditioned media. Monocyte chemotaxis was
signiﬁcantly upregulated in response to CoCl2 conditioned media
compared to the untreated control (Po0.001) (Fig. 2A and B). Thisincrease was signiﬁcantly inhibited by pre-treatment of MonoMac
6 cells with CLI-095 (Po0.001). Monocyte migration was also
increased in response to conditioned media from TLR4-speciﬁc LPS
and the effect was also abrogated by CLI-095 (Po0.001) demon-
strating that CLI-095 speciﬁcally inhibits the TLR4 signalling
pathway. Untreated conditioned media did not affect monocyte
chemotaxis and there was no difference with the addition of CLI-
095 (P¼0.78). This shows that CLI-095 alone does not affect che-
mokine secretion, nor does it cause monocyte chemotaxis down a
concentration gradient.
H. Lawrence et al. / Biochemistry and Biophysics Reports 7 (2016) 374–378378Neutrophil chemotaxis was also investigated and similar effects
were observed to those in monocytes (Fig. 3A and B). Cobalt
conditioned media induced neutrophil chemotaxis (Po0.001) and
was signiﬁcantly decreased in the presence of the TLR4 inhibitor
(Po0.001), as was LPS-stimulated migration as a positive control
(Po0.001). The untreated controls with and without CLI-095 had
no effect on neutrophil migration and were not signiﬁcantly dif-
ferent from each other (P¼0.61).4. Discussion
This study set out to determine the chemotactic properties of
cells stimulated with cobalt ions and the role of TLR4 in these re-
sponses. We have clearly shown that cobalt-mediated activation of
TLR4 increases the release of inﬂammatory cytokines, speciﬁcally
CCL20 and IL-6. This supports out previous work showing similar
effects on release of IL-8 and CXCL10 [9]. Furthermore, we have
demonstrated that conditioned media from cobalt-stimulated
MonoMac 6 cells causes increased chemotaxis of primary mono-
cytes and neutrophils. The observed monocyte and neutrophil
chemotaxis can be attributed to TLR4 as the small molecule TLR4
antagonist CLI-095 abrogated the response. This demonstrates that
chemokines capable of attracting innate immune cells are secreted
via direct cobalt activation of the TLR4 signalling pathway.
Given the increased chemokine secretion observed in response
to cobalt in previous studies it could be assumed that any condi-
tioned media from cobalt-stimulated cells would be chemotactic.
However it is important to note that many cytokines and che-
mokines, such as IL-10, can dampen an inﬂammatory response in
order to modulate immunity and prevent systemic shock [18,19].
Furthermore, while research has shown that cobalt induces certain
individual pro-inﬂammatory factors including IL-8 [9] and CCL2
[10], it is the cumulative effect of chemokines that ultimately in-
ﬂuences migration. Before the current study it was not fully un-
derstood whether cobalt ions would cause a chemotactic response
or induce a chemokine proﬁle that skewed the response against
migration. Data presented here shows clearly that the overall co-
balt-induced chemokine proﬁle in monocytes is pro-migratory for
both primary monocytes and neutrophils.
Based on our understanding of the effects of factors such as IL-8
and CCL2 on neutrophil and monocyte migration respectively,
coupled with their known secretion in response to TLR4 activation
by cobalt [9,20], it can be surmised that they are at least in part
responsible for the observed chemotaxis. Future work will involve
neutralising different chemokines and their receptors to further
investigate their individual role in the chemotaxis response to
cobalt ions. Work will also be undertaken to determine whether or
not the migration of monocytes and neutrophils affects sub-
sequent recruitment of adaptive immune cells such as lympho-
cytes, which are also known to be present around failed MoM hip
replacements [4,21].
In conclusion, this study demonstrates the role of TLR4 in co-
balt-mediated inﬂammatory cytokine secretion and innate im-
mune cell chemotaxis, and highlights TLR4 as a potential ther-
apeutic target in preventing inﬂammatory cell inﬁltration of MoM
peri-implant tissues.Acknowledgements
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